Exenatide implant (Vivani Medical)

艾塞那肽植入物 (Vivani Medical)

Report date: 2024/12/27 10:50:27

Base Information

Drug NameExenatide implant (Vivani Medical)

Drug Alias Name微小GLP-1受体激动剂皮下植入物Miniature Long-Term Subdermal GLP-1 Drug ImplantNPM-119NPM-115

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVivani Medical Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsOverweightObesityDiabetes Mellitus, Type 2

Inactive IndicationsN/A

ATC CodeN/A